II.

Predictive Value for Biochemical Recurrence in the Neoadjuvant Group

	Univariate analysis			Multivariate analysis
	HR	95% CI	P value	HR	95% CI	P value
Serum PSA level at diagnosis	1.02	0.98–1.05	0.396	1.01	0.96–1.06	0.648
High Gleason score (≥8)	2.28	0.56–9.30	0.250	1.23	0.46–3.26	0.684
High pT stage (pT3)	1.86	0.80–4.34	0.149	0.87	0.30–2.54	0.802
High CD105-MVD (>20/HPF)	4.68	1.83–12.02	0.001	4.45	1.61–12.26	0.004

HR, hazard ratio; CI, confidential interval; PSA, prostate-specific antigen; MVD, microvessel density.